Home/Filings/4/0001127602-25-004347
4//SEC Filing

Himmelreich Jeffrey C 4

Accession 0001127602-25-004347

CIK 0001878313other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:09 PM ET

Size

5.3 KB

Accession

0001127602-25-004347

Insider Transaction Report

Form 4
Period: 2025-02-10
Himmelreich Jeffrey C
Head of Finance
Transactions
  • Award

    Stock Options

    2025-02-10+10,00010,000 total
    Exercise: $1.81Exp: 2035-02-10Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0002001189

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:09 PM ET
Size
5.3 KB